The knockdown of TRIM14 significantly reduced the proliferation of AML cells (p < 0.05), whereas its overexpression exhibited reversed effects (p < 0.05) (Fig. 1D–E). This evidence concerns the gene TRIM14 and acute myeloid leukemia.